Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Volumn 6, Issue 7, 1988, Pages 1088-1097

  Shimoyama, M ^a   Ota, K ^a   Kikuchi, M ^a   Yunoki, K ^a   Konda, S ^a   Takatsuki, K ^a   Ichimaru, M ^a   Tominaga, S ^a   Tsugane, S ^a   Minato, K ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISOLONE; VAP CYCLO PROTOCOL; VAP-CYCLO PROTOCOL; VEPA M PROTOCOL; VEPA-M PROTOCOL; VINCRISTINE;

ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REMISSION; T LYMPHOCYTE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; DELTARETROVIRUS INFECTIONS; DOXORUBICIN; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; REMISSION INDUCTION; T-LYMPHOCYTES; VINCRISTINE;

EID: 0024041713     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1988.6.7.1088     Document Type: Article

References (0)